Researchers are excited about the medication , a groundbreaking dual agonist showing promising outcomes in early trials for weight reduction . It functions by targeting both systems: GLP-1 and GIP, that , when stimulated, assist regulate hunger and improve calorie burn. Preliminary reports indicate considerable body reduction and likely advantages